Your browser doesn't support javascript.
loading
Oligonucleotide mapping via mass spectrometry to enable comprehensive primary structure characterization of an mRNA vaccine against SARS-CoV-2.
Gau, Brian C; Dawdy, Andrew W; Wang, Hanliu Leah; Bare, Bradley; Castaneda, Carlos H; Friese, Olga V; Thompson, Matthew S; Lerch, Thomas F; Cirelli, David J; Rouse, Jason C.
Afiliação
  • Gau BC; BioTherapeutics Pharmaceutical Sciences, Pfizer Inc, Chesterfield, MO, USA. Brian.Gau@pfizer.com.
  • Dawdy AW; BioTherapeutics Pharmaceutical Sciences, Pfizer Inc, Chesterfield, MO, USA. Andrew.Dawdy@pfizer.com.
  • Wang HL; BioTherapeutics Pharmaceutical Sciences, Pfizer Inc, Chesterfield, MO, USA.
  • Bare B; BioTherapeutics Pharmaceutical Sciences, Pfizer Inc, Chesterfield, MO, USA.
  • Castaneda CH; BioTherapeutics Pharmaceutical Sciences, Pfizer Inc, Chesterfield, MO, USA.
  • Friese OV; BioTherapeutics Pharmaceutical Sciences, Pfizer Inc, Chesterfield, MO, USA.
  • Thompson MS; BioTherapeutics Pharmaceutical Sciences, Pfizer Inc, Andover, MA, USA.
  • Lerch TF; BioTherapeutics Pharmaceutical Sciences, Pfizer Inc, Chesterfield, MO, USA.
  • Cirelli DJ; BioTherapeutics Pharmaceutical Sciences, Pfizer Inc, Andover, MA, USA.
  • Rouse JC; BioTherapeutics Pharmaceutical Sciences, Pfizer Inc, Andover, MA, USA.
Sci Rep ; 13(1): 9038, 2023 06 03.
Article em En | MEDLINE | ID: mdl-37270636

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espectrometria de Massas em Tandem / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espectrometria de Massas em Tandem / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article